semaglutide day 2 Dosing Now that oral semaglutide (#wegovy)

25 (Paid through June 25)

Current practice allows extrapolation where the mechanism of action is shared across indications and the clinical development program used a sensitive patient population

Patients received once-daily injections of liraglutide or placebo for 52 weeks in addition to standard medical care and medication such as l-DOPA

Fill-finish lines already operating near capacity for the existing semaglutide portfolio would face additional qualification burdens, particularly if the 7.2 mg presentation demands a reformulated excipient profile or altered viscosity specifications

It is therefore not clear how much of the placebo effect resulted in the drug treatment outcome

More than predicted